Skip to content

SANUWAVE Health, Inc. SNWV Conversion of warrants to common stock

Conversion of warrants to common stock at other companies

Applied Digital logo
Applied DigitalAPLD
$1.25K
Grindr logo
GrindrGRND
$0-100%
TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
$0-100%
Owlet logo
OwletOWLT
$11.72M
ALH
Alliance Laundry Holdings Inc.ALH
45.3M
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept snwv:ConversionOfWarrantsToCommonStock.

The official record: SANUWAVE Health, Inc.’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s conversion of warrants to common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s conversion of warrants to common stock?
SANUWAVE Health, Inc. (SNWV) reported conversion of warrants to common stock of $0 in Q4 2025.
How has SANUWAVE Health, Inc.'s conversion of warrants to common stock changed year-over-year?
SANUWAVE Health, Inc.'s conversion of warrants to common stock decreased by 100.0% year-over-year, from $10.35M to $0.
What does conversion of warrants to common stock mean?
Tracks the non-cash movement of equity instruments as warrants are exercised or converted into common shares. This activity reflects the transition of potential equity claims into actual ownership, which impacts the company's total share count and capital structure. Monitoring this helps investors understand the pace of dilution and the conversion of debt-related equity incentives into permanent capital.